A low body mass index is correlated with poor survival after allogeneic stem cell transplantation

Haematologica

Volumn 88, Issue 9, 2003, Pages 1044-1052

  Le Blanc, Katarina ^a   Ringdén, Olle ^b   Remberger, Mats ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Adults; Allogeneic stem cell transplantation; Body weight; Leukemia

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOTRANSPLANTATION; ARTICLE; BODY MASS; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; BACTEREMIA; BODY MASS INDEX; CAUSE OF DEATH; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RISK FACTORS; STEM CELL TRANSPLANTATION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0141478900     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, et al. Bone-marrow transplantation I and II. N Engl J Med 1975;292:832-95.
2. Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman RE, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk of relapse associated with T-cell depletion. Ann Intern Med 1988;108:806-14.
3. Barrett AJ, Horowitz MM, Gale RP. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989;74:862-71.
4. Ringdén O. Allogeneic bone marrow transplantation for hematological malignancies. Controversies and recent advances. Acta Oncol 1997;36:549-64.
5. Appelbaum FR. The current status of hematopoietic cell transplantation. Ann Rev Med 2003;54:491-512.
6. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, et al. t of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989;320:197-204.
7. Beatty PG, Anasetti C, Hansen JA, Longton GM, Sanders JE, Martin PJ, et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993;81:249-53.
8. Ringdén O. Bone marrow transplantation using unrelated donors for hematological malignancies. Med Oncol 1997;14:11-22.
9. Sierra J, Storer B, Hansen J, Bjerke JW, Martin PJ, Petersdorf EW, et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997;89:4226-35.
10. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993;119:655-60.
11. Fleming DR, Rayens MK, Garrison J. Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study. Am J Med 1997;102:265-8.
12. Clarke B, Engler H. Patients with morbid obesity don't get life-saving bone marrow transplants. Obes Surg 1999;9:77-9.
13. Ritchie DS, Wirth A, Grigg AP. Successful transplant outcome in a morbidly obese patient with acute myeloblastic leukamia. Leuk Lymphoma 2001;42:1111-4.
14. Coghlin-Dickson TM, Kusnierz-Glaz CR, Blume KG, Negrin RS, Hu WW, Shizuru JA, et al. Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biol Blood Marrow Transplant 1999;5:299.
15. Meloni G, Proia A, Capria S, Romano A, Trapé G, Trisolini SM, Vignetti M, Mandelli F. Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant 2001;28:365-7.
16. Eriksson K, Cederholm T, Palmblad J. Nutrition and acute leukemia in adults. Relation between nutritional status and infectious complication during remission induction. Cancer 1998;82:1071-7.
17. Deeg HJ, Seidel K, Bruemmer B, Pepe MS, Appelbaum FR. Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 1995;15:461-8.
18. Benn RT, Indices of height and weight as measures of obesity. Br J Prev Soc Med 1970;24:64.
19. Ringdén O, Baring;ryd I, Johansson B, Gahrton G, Groth CG, Lundgren G, et al. Increased mortality by septicemia, interstitial pneumonitis and pulmonary fibrosis among bone marrow transplant recipients receiving an increased mean dose rate of total irradiation. Acta Radiol Oncol 1983;22:423-8.
20. Ringdén O, Ruutu T, Remberger M, Nikoskelainen J, Volin L, Vindelov L, et al. A randomized trial comparing busulphan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia. Blood 1994;83:2723-30.
21. Ringdén O, Pihlstedt P, Markling L, Aschan J, Baryd I, Ljungman P, et al. Prevention of graft-versus-host disease with T-cell depletion or cyclosporine and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991;7:221-6.
22. Ringdén O, Remberger M, Persson U, Ljungman P, Aldener A, Andstrom E, et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995;15:619-25.
23. Storb R, Epstein R, Graham T, Thomas E. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 1970;9:240-6.
24. Ringdén O, Bäckman L, Lönnqvist, B, Heimdahl A, Lindholm A, Bolme P, et al. A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies. Bone Marrow Transplant 1986;1:41-51.
25. Deeg H, Storb R, Appelbaum F, Kennedy MS, Graham TC, Thomas ED. Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates. Transplantation 1984;37:62-5.
26. Storb R, Deeg H, Whitehead J, Appelbaum F, Beatty P, Bensinger W, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med 1986;314:729-35.
27. Aschan J, Ringdén O, Andström E, Ljungman P, Lönnqvist B, Remberger M. Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients. Bone Marrow Transplant 1994;14:79-87.
28. Carlens S, Aschan J, Remberger M, Dilber S, Ringdén O. Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukemia. Bone Marrow Transplant 1999;24:629-35.
29. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
30. Cox D. Regression models and life-tables. J R Stat Soc (Series B) 1972;34:187-220.
31. Weir J, Reilly JJ, McColl JH, Gibson BES. No evidence for an effect of nutritional status at diagnosis on prognosis in children with acute lymphoblastic leukemi. J Pediatr Hematol/Oncol 1998;20:534-8.
32. Rasmussen F, Johansson M, Hansen HO. Trends in overweight and obesity among 18-y old males in Sweden between 1971 and 1995. Acta Paediatrica 1999;88:365-7.
33. Palmblad J. Malnutrition associated immune deficiency syndrome: clues to mechanisms. Acta Med Scand 1987;222:1-3.
34. Dickson TM, Kusnierz-Glaz CR, Blume KG, Negri US, Hu WW, Shizuru JA, et al. Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biol Blood Marrow Transplant 1999;5:299-305.
35. Tracey KJ, Wei H, Manogue KR, Fong Y, Hese DG, Ngyuen HT, et al. Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 1988;167:1211-27.
36. Cederholm T, Wretlind B, Heliström K, Andersson B, Engström L, Brismar K, et al. Enhanced generation of interleukins 1b and 6 may contribute to the cachexia of chronic disease. Am J Clin Nutr 1997;65:876-82.